We are a global science-driven biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China, including Mainland China, Hong Kong Taiwan and Macau, and other Asian markets. China is the second-largest pharmaceutical market in the world.  We have entered into high-value strategic […]

Our mission is to transform the way we power our world for a more sustainable future. We were formed in 2018 via a joint venture between Siemens and AES. Members of our board of directors and leadership team were part of the founding team at AES Energy Storage that conceived and tested the world’s first lithium-ion […]

We intend to focus on technology companies that operate in the marketplace, financial technology (“FinTech”) and Software-as-a-service (“SaaS”) verticals within Europe, Latin America (“Latam”) and the United States (“U.S.”), where we believe our management team, board members and advisors have a competitive advantage based on their prior experiences and investments. (Incorporated in the Cayman Islands) […]

We intend to focus our search on a U.S. domiciled Financial Technology (“FinTech”) company and will leverage our deep domain expertise, investing track record, and extensive networks in order to pursue a business combination with a high-quality growth-oriented company in the FinTech business-to-business (“B2B”) software-as-a-service (“SaaS”) sector. Our company is led by Logan Allin, our […]

Ensemble Health Partners is a leading provider of technology-enabled revenue cycle management (RCM or medical billing) solutions for health systems, including hospitals and affiliated physician groups. We built our RCM platform to deliver significant and sustainable financial performance improvement for our clients, enhance the patient experience, and better enable providers to focus on clinical care. […]

(Note: Candela Medical withdrew its IPO plans in an SEC document dated Sept. 2, 2022. Previously: Candela Medical postponed its IPO “due to market conditions” on Oct. 27, 2021, hours ahead of when the IPO was scheduled for pricing.)  We are a leading provider of advanced medical device solutions for a broad range of aesthetic […]

We pioneered a new category of software, the Intelligent Data Management Cloud, an AI-powered platform that connects, manages and unifies data across any multi-cloud, hybrid system. As of June 30, 2021, the company had approximately 5,700 customers in over 100 countries and territories worldwide, including 9 of the Fortune 10, 84 of the Fortune 100, and […]

We are a leading provider of interconnect and other intellectual property (“IP”) technology that manages the on-chip communications in System-on-Chip (“SoC”) semiconductor devices. Our products enable our customers to deliver increasingly complex SoCs that not only process data but are also able to make decisions. Growth in the total addressable market (“TAM”) for our solutions is being driven by […]

Our objective is to identify and acquire a high quality, high growth business in the global health and wellness industry, although we reserve the right to pursue an initial business combination target in any sector, industry, or geographic location. (Incorporated in the Cayman Islands) More specific sectors in our targeted industry include, but are not […]

We intend to identify and acquire a business focusing on industrial technology. We will seek to acquire one or more businesses with an aggregate enterprise value of $700 million or greater. We will concentrate on sourcing business combination opportunities with industrial technology businesses, with particular emphasis on those that align with several key themes commonly referred […]